Led · Equity · Nov 2021

Founded in 2011 and headquartered in Ottawa, Ontario, Fullscript provides a clinical platform that enables providers to prescribe and fulfill evidence-based supplements, manage labs, and track patient adherence. The company supports over 100,000 providers and 10 million patients, positioning it as a sizable player in preventative and whole-person care. Fullscript’s core product suite combines fulfillment, lab capabilities, and intuitive clinical tools to improve patient outcomes and practitioner efficiency. The company plans to continue advancing its technology and expanding its services to empower more practitioners to deliver personalized, proactive care. The articles emphasize strong investor confidence in Fullscript’s model and leadership, evidenced by an expanded investment to support its next phase of growth. No revenue or valuation figures were disclosed in the coverage. Fullscript operates a wholesale backend and storefront platform that helps practitioners source supplements, fulfill prescriptions via its dispensary, and manage integrated treatment plans with links into electronic health records. The company offers roughly 20,000 products from about 300 brands and has about 30,000 practitioners subscribing to its platform. Fullscript plans to use new funding to expand across North America and build more technology for customers, including analytics and patient tools for monitoring progress and purchases. Payments for products are made directly by patients today, and insurance is not part of Fullscript’s backend. The company positions itself against larger online sellers and new entrants in the space while arguing integrative approaches are gaining broader acceptance among practitioners and health systems. Fullscript was founded in 2012 and has grown largely by being bootstrapped prior to recent external investment. Fullscript is a nutraceutical e-prescribing platform that enables healthcare practitioners in the US and Canada to dispense professional-grade nutritional supplements through an online e-prescribing system. Patients fulfill prescriptions online and practitioner-recommended products are shipped directly, minimizing the need for practitioners to manage large physical inventories. The company has begun integrating with an increasing number of Electronic Health Record partners to build a database of nutritional supplement research linked to ingredients and conditions. This work includes tools for drug-nutrient depletion and interaction analysis to inform practitioners on safe, effective nutraceutical use. Fullscript was created after a June 2018 merger between Natural Partners, a 24-year-old specialty wholesale distributor based in Scottsdale, Arizona, and Fullscript, an eight-year-old tech startup based in Ottawa, Ontario. Led by CEO Fran Towey, the company intends to use newly raised funds to scale its online technology platform, Fullscript. In May 2019 the company raised $25M in Series B financing.